95 related articles for article (PubMed ID: 15074015)
1. [Study of interleukins and their soluble receptors in B-cell chronic lymphatic leukemia].
Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
Pol Merkur Lekarski; 2004 Jan; 16(91):22-5. PubMed ID: 15074015
[TBL] [Abstract][Full Text] [Related]
2. [Interleukin-6 and interleukin-12 blood levels in patients with chronic B-cell lymphocytic leukemia].
Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
Pol Merkur Lekarski; 2004 Feb; 16(92):157-61. PubMed ID: 15176301
[TBL] [Abstract][Full Text] [Related]
3. Cytokine and adhesion molecule concentrations in blood of patients with B-cell chronic lymphocytic leukaemia with regard to disease progression.
Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
Rocz Akad Med Bialymst; 2003; 48():90-4. PubMed ID: 14737950
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters.
Hulkkonen J; Vilpo J; Vilpo L; Koski T; Hurme M
Haematologica; 2000 Jun; 85(6):600-6. PubMed ID: 10870116
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
[TBL] [Abstract][Full Text] [Related]
7. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
[TBL] [Abstract][Full Text] [Related]
8. [Examination of interleukin levels and growth factor from blood platelets in leukemia].
Kiersnowska-Rogowska B; Rogowski F; Petelski T; Citko A; Jaroszewicz E; Bielawiec M
Pol Tyg Lek; 1996 May; 51(19-22):281-2, 288. PubMed ID: 9289710
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression.
Aguilar-Santelises M; Magnusson R; Svenson SB; Loftenius A; Andersson B; Mellstedt H; Jondal M
Clin Exp Immunol; 1991 Jun; 84(3):422-8. PubMed ID: 2044220
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia.
Marta R; Goette N; Lev P; Heller P; Kornblihtt L; Vassallú P; Glembotsky A; Pirola C; Molinas F
Haematologica; 2004 Jun; 89(6):657-63. PubMed ID: 15194532
[TBL] [Abstract][Full Text] [Related]
11. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia.
Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M
Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607
[TBL] [Abstract][Full Text] [Related]
14. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
Spaner DE; Hammond C; Mena J; Shi Y
Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
[TBL] [Abstract][Full Text] [Related]
15. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.
Jabłońska E; Kiersnowska-Rogowska B; Rogowski F; Parfieńczyk A; Puzewska W; Bukin M
Rocz Akad Med Bialymst; 2005; 50():204-7. PubMed ID: 16358967
[TBL] [Abstract][Full Text] [Related]
16. Interleukins, TNF-alpha and beta-2M in patients with B cell chronic lymphocytic leukemia.
Mavridis AK; Tsiara S; Makis A; Chaidos A; Christou L; Seferiadis K; Bourantas KL
J Exp Clin Cancer Res; 1998 Dec; 17(4):445-8. PubMed ID: 10089066
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
18. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
[TBL] [Abstract][Full Text] [Related]
19. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress accelerates spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes.
Djurdjevic P; Zelen I; Ristic P; Jovanovic I; Jakovljevic V; Baskic D; Popovic S; Arsenijevic N
J BUON; 2009; 14(2):281-7. PubMed ID: 19650179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]